ClinicalTrials.govpublic full text
Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.
relapsed or refractory diffuse large b-cell lymphoma (r/r dlbcl)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 226249
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.